logo image
search icon
Clinical Laboratory Tests Market

Clinical Laboratory Tests Market Size, Share & Trends Analysis Report By Type (Complete Blood Count, HGB/HCT Testing, Basic Metabolic Panel Testing, BUN Creatinine Testing, Electrolytes Testing, HbA1c Testing, Comprehensive Metabolic Panel Testing, Liver Panel Testing), By End-use (Central Laboratories, Primary Clinics), By Region, And Segment Forecasts, 2023-2031

Report ID : 1689 | Published : 2023-04-04 | Pages: 180 | Format: PDF/EXCEL

The Global Clinical Laboratory Tests Market Size is valued at 108.55 billion in 2022 and is predicted to reach 221.50 billion by the year 2031 at an 8.46% CAGR during the forecast period for 2023-2031.

The market for clinical laboratory tests is expanding due to factors like an aging population, an expansion in the prevalence of target diseases, and the development of creative solutions to suit the market's increased need for clinical testing. The spread of COVID-19 has significantly impacted the healthcare and testing industries.

Clinical Laboratory Tests Market

The pandemic's negative consequences have been seen in the market for clinical laboratory tests. For instance, LabCorp saw an 8.9% decrease in total sales in 2020. This is also because fewer people underwent routine medical examinations during the pandemic, which decreased the number of clinical chemistry tests performed. However, the frequency of tests has returned to normal, suggesting that the COVID-19 epidemic has no impact in the long term.

The WHO reports that in most industrialized economies, the average life expectancy has surpassed 80 years. Aging is a significant risk factor for the emergence of infectious diseases due to the interaction of various environmental and genetic factors that impact immunity and metabolism, changing the function of organs. Hence, diagnostics and screening might be crucial in treating general health. Therefore, as the elderly population grows, so does the demand for acute and long-term healthcare, fueling the expansion of the global market. 

Recent Developments:

  • In September 2022, The establishment of Bionano Labs, a new company that integrates the clinical testing services formerly provided by Lineagen with the optical genome mapping (OGM) data services of Bionano, was announced by Bionano Genomics Inc. Also, it announced the debut of the first OGM-based test created by Bionano Labs (LDT). 

Competitive Landscape:

Some of the Clinical Laboratory Tests market players are:

  • Abbott
  • ARUP Laboratories;
  • Bioscientia Healthcare GmbH (Germany)
  • Charles River Laboratories (U.S.)
  • Cinven;
  • Clinical Reference Laboratory, Inc.;
  • Fresenius Medical Care AG & Co. KGaA (Germany)
  • Genoptix, Inc. (U.S.)
  • Healthscope (Australia)
  • Laboratory Corporation of America Holdings;
  • Merck KGaA (Germany)
  • NeoGenomics Laboratories (U.S.)
  • OPKO Health, Inc.;
  • QIAGEN (Germany)
  • Quest Diagnostics Incorporated.;
  • Siemens Healthcare Private Limited (Germany)
  • Sonic Healthcare Limited
  • Synnovis Group LLP;
  • The Laboratory Glassware Co. (U.S.)
  • Tulip Diagnostics (P) Ltd. (India)
  • UNILABS; 

Market Segmentation:

The Clinical Laboratory Tests market is segmented based on type and end-use. Based on type, the market is segmented as Complete Blood Count, HGB/ HCT testing, Basic Metabolic Panel Testing, BUN Creatinine Testing, Electrolytes Testing, HbA1c Testing, Comprehensive Metabolic Panel Testing, Liver Panel Testing (Hepatitis, Bile Duct Obstruction, Liver Cirrhosis, Liver Cancer, Bone Disease, Autoimmune Disorders, Others) Renal Panel Testing, Lipid Panel Testing, and Cardiovascular Panel Testing. By end-use, the market is segmented into Central Laboratories, and Primary Clinics.

Based On Type, The HbA1c Tests Segment Is Accounted As A Major Contributor In The Clinical Laboratory Tests Market

The segment for HbA1c tests held the largest market share. Although patients with fluctuating levels of HbA1c run a higher risk of developing problems from diabetes, it is projected that the growing number of patients with diabetes and aberrant cholesterol levels will fuel market expansion. Furthermore, the introduction of more recent laboratory testing is anticipated to further fuel market expansion. For instance, OmegaQuant introduced the HbA1c Test in May 2022 to measure the level of blood sugar in the body. A home collection device for diabetes risk testing called LabCorp on demand was also introduced by LabCorp in May 2022. Such fresh launches provide accessibility to a variety of lab tests for determining blood sugar levels.

Central Laboratories Witness Growth At A Rapid Rate

Over the projected period, the central laboratories sector is anticipated to extend at the fastest rate. The intense market penetration and procedure volumes are credited with the segment's growth. Another significant factor projected to propel the market is the rising number of efforts undertaken by governments to provide various services, such as reimbursement for clinical laboratory testing. For the integration of many tests, including microbiology testing, several healthcare organizations are collaborating with laboratories. Furthermore, a sizable portion comes from a huge number of laboratories in developing and emerging countries. Regulatory agencies are also enhancing laboratory services and simplifying the diagnosing process.

The North America Clinical Laboratory Tests Market Holds A Significant Regional Revenue Share

The region with the biggest market share is anticipated to hold onto that position during the projection period. This might be linked to the region's growing senior population, increased chronic illness prevalence, including cancer, and intense market penetration of cutting-edge diagnostic techniques. One of the substantial causes of death in North America, according to the American Cancer Society, is cancer. Prostate cancer in males and breast cancer in women are the two most frequently diagnosed cancers. The regional market is anticipated to be driven by factors like rising patient awareness and a growing inclination for novel techniques.

Clinical Laboratory Tests Market Report Scope:

Report Attribute

Specifications

Market size value in 2022

USD 108.55 Bn

Revenue forecast in 2031

USD 221.50 Bn

Growth rate CAGR

CAGR of 8.46 % from 2023 to 2031

Quantitative units

Representation of revenue in US$ Billion, and CAGR from 2023 to 2031

Historic Year

2019 to 2022

Forecast Year

2023-2031

Report coverage

The forecast of revenue, the position of the company, the competitive market statistics, growth prospects, and trends

Segments covered

Animal Type, Product, Distribution Channel, And Indication

Regional scope

North America; Europe; Asia Pacific; Latin America; Middle East & Africa

Country scope

U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; Southeast Asia; South Korea; Southeast Asia

Competitive Landscape

Quest Diagnostics Incorporated.; Abbott; Cinven; Laboratory Corporation of America Holdings; ARUP Laboratories; OPKO Health, Inc.; UNILABS; Clinical Reference Laboratory, Inc.; Synnovis Group LLP; Sonic Healthcare Limited.

Customization scope

Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape.

Pricing and available payment methods

Explore pricing alternatives that are customized to your particular study requirements.

Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Clinical Laboratory Tests Market Snapshot

Chapter 4. Global Clinical Laboratory Tests Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis

Chapter 5. Market Segmentation 1: by Product Type Estimates & Trend Analysis
5.1. by Product Type & Market Share, 2019 & 2031
5.2. Market Size (Value (US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Product Type:

5.2.1. Complete Blood Count
5.2.2. HGB/ HCT Testing
5.2.3. Basic Metabolic Panel Testing
5.2.4. BUN Creatinine Testing
5.2.5. Electrolytes Testing
5.2.6. HbA1c Testing
5.2.7. Comprehensive Metabolic Panel Testing

5.2.8. Liver Panel Testing

5.2.8.1. Hepatitis
5.2.8.2. Bile Duct Obstruction
5.2.8.3. Liver Cirrhosis
5.2.8.4. Liver Cancer
5.2.8.5. Bone Disease
5.2.8.6. Autoimmune Disorders
5.2.8.7. Others

5.2.9. Renal Panel Testing
5.2.10. Lipid Panel Testing
5.2.11. Cardiovascular Panel Tests

Chapter 6. Market Segmentation 2: by End-Use Estimates & Trend Analysis
6.1. by End-Use & Market Share, 2019 & 2031
6.2. Market Size (Value (US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following by End-Use:

6.2.1. Central Laboratories

6.2.1.1. Complete Blood Count
6.2.1.2. HGB/ HCT testing
6.2.1.3. Basic Metabolic Panel Testing
6.2.1.4. BUN Creatinine Testing
6.2.1.5. Electrolytes Testing
6.2.1.6. HbA1c Testing
6.2.1.7. Comprehensive Metabolic Panel Testing
6.2.1.8. Liver Panel Testing
6.2.1.9. Renal Panel Testing
6.2.1.10. Lipid Panel Testing
6.2.1.11. Cardiovascular Panel Tests

6.2.2. Primary Clinics

6.2.2.1. Complete Blood Count
6.2.2.2. HGB/ HCT testing
6.2.2.3. Basic Metabolic Panel Testing
6.2.2.4. BUN Creatinine Testing
6.2.2.5. Electrolytes Testing
6.2.2.6. HbA1c Testing
6.2.2.7. Comprehensive Metabolic Panel Testing
6.2.2.8. Liver Panel Testing
6.2.2.9. Renal Panel Testing
6.2.2.10. Lipid Panel Testing
6.2.2.11. Cardiovascular Panel Tests

Chapter 7. Clinical Laboratory Tests Market Segmentation 3: Regional Estimates & Trend Analysis

7.1. North America

7.1.1. North America Clinical Laboratory Tests Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2023-2031
7.1.2. North America Clinical Laboratory Tests Market Revenue (US$ Million) Estimates and Forecasts by End-Use, 2023-2031
7.1.3. North America Clinical Laboratory Tests Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031

7.2. Europe

7.2.1. Europe Clinical Laboratory Tests Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2023-2031
7.2.2. Europe Clinical Laboratory Tests Market Revenue (US$ Million) Estimates and Forecasts by End-Use, 2023-2031
7.2.3. Europe Clinical Laboratory Tests Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031

7.3. Asia Pacific

7.3.1. Asia Pacific Clinical Laboratory Tests Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2023-2031
7.3.2. Asia Pacific Clinical Laboratory Tests Market Revenue (US$ Million) Estimates and Forecasts by End-Use, 2023-2031
7.3.3. Asia Pacific Clinical Laboratory Tests Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031

7.4. Latin America

7.4.1. Latin America Clinical Laboratory Tests Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2023-2031
7.4.2. Latin America Clinical Laboratory Tests Market Revenue (US$ Million) Estimates and Forecasts by End-Use, 2023-2031
7.4.3. Latin America Clinical Laboratory Tests Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031

7.5. Middle East & Africa

7.5.1. Middle East & Africa Clinical Laboratory Tests Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2023-2031
7.5.2. Middle East & Africa Clinical Laboratory Tests Market Revenue (US$ Million) Estimates and Forecasts by End-Use, 2023-2031
7.5.3. Middle East & Africa Clinical Laboratory Tests Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031

Chapter 8. Competitive Landscape

8.1. Major Mergers and Acquisitions/Strategic Alliances

8.2. Company Profiles


8.2.1. Abbott
8.2.2. ARUP Laboratories;
8.2.3. Bioscientia Healthcare GmbH (Germany)
8.2.4. Charles River Laboratories (U.S.)
8.2.5. Cinven;
8.2.6. Clinical Reference Laboratory, Inc.;
8.2.7. Fresenius Medical Care AG & Co. KGaA (Germany)
8.2.8. Genoptix, Inc. (U.S.)
8.2.9. Healthscope (Australia)
8.2.10. Laboratory Corporation of America Holdings;
8.2.11. Merck KGaA (Germany)
8.2.12. NeoGenomics Laboratories (U.S.)
8.2.13. OPKO Health, Inc.;
8.2.14. QIAGEN (Germany)
8.2.15. Quest Diagnostics Incorporated.;
8.2.16. Siemens Healthcare Private Limited (Germany)
8.2.17. Sonic Healthcare Limited
8.2.18. Synnovis Group LLP;
8.2.19. The Laboratory Glassware Co. (U.S.)
8.2.20. Tulip Diagnostics (P) Ltd. (India)
8.2.21. UNILABS;
8.2.22. Other Prominent Players

Segmentation of Clinical Laboratory Tests Market-

Clinical Laboratory Tests Market By Type-

  • Complete Blood Count
  • HGB/ HCT testing
  • Basic Metabolic Panel Testing
  • BUN Creatinine Testing
  • Electrolytes Testing
  • HbA1c Testing
  • Comprehensive Metabolic Panel Testing
  • Liver Panel Testing
    • Hepatitis
    • Bile Duct Obstruction
    • Liver Cirrhosis
    • Liver Cancer
    • Bone Disease
    • Autoimmune Disorders
    • Others
  • Renal Panel Testing
  • Lipid Panel Testing
  • Cardiovascular Panel Tests

Clinical Laboratory Tests Market

Clinical Laboratory Tests Market By End-Use-

  • Central Laboratories
    • Complete Blood Count
    • HGB/ HCT testing
    • Basic Metabolic Panel Testing
    • BUN Creatinine Testing
    • Electrolytes Testing
    • HbA1c Testing
    • Comprehensive Metabolic Panel Testing
    • Liver Panel Testing
    • Renal Panel Testing
    • Lipid Panel Testing
    • Cardiovascular Panel Tests
  • Primary Clinics
    • Complete Blood Count
    • HGB/ HCT testing
    • Basic Metabolic Panel Testing
    • BUN Creatinine Testing
    • Electrolytes Testing
    • HbA1c Testing
    • Comprehensive Metabolic Panel Testing
    • Liver Panel Testing
    • Renal Panel Testing
    • Lipid Panel Testing
    • Cardiovascular Panel Tests

 

Clinical Laboratory Tests Market By Region-

North America-

  • The US
  • Canada
  • Mexico

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • South East Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

user icon
office icon
mail icon
call icon

This website is secure, and we do not share your personal information with any third party. Privacy Policy

Need Customization
Need specific information/chapter from the report of the custom data table, graph or complete report? Tell us more.

Frequently Asked Questions

How big is the Clinical Laboratory Tests Market?

Clinical Laboratory Tests Market expected to grow at an 8.46% CAGR during the forecast period for 2023-2031

Quest Diagnostics Incorporated.; Abbott; Cinven; Laboratory Corporation of America Holdings; ARUP Laboratories; OPKO Health, Inc.; UNILABS; Clinical R

Our Clients

  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo

Media Citations

  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo

Growth opportunities and latent adjacency in Biotechnology

Select Licence Type
$4456
$7786
$10000
$1200
Get Your GTM Strategy

Navigate market entry with channel selection, launch strategy & timeline, and pricing model support.

Equip yourself with the insights needed to develop a winning go-to-market strategy

Get real-time updates and joint control over project direction with our collaborative approach